for rights to an oral GLP-1 RA asset outside of China, with up to $1.9 billion in biobucks (sorry, milestone payments associated with the development, regulatory approval and commercialization of the candidate, as well as royalties on sales)
Why This Matters To be clear: GLP-1 medications dont directly rot teeth
At those doses it acts as a powerful antioxidant and immune-modulating agent
Key Leaders: Steve Hoerter, Chief Executive Officer
10.1093/nar/gkab951 Summary Keywords glutathione synthetase deficiency, 5-oxoprolinuria, glutathione synthetase gene variation, newborn, inherited metabolic disease, case report Citation Wu X, Jiao J, Xia Y, Yan X, Liu Z, Cao Y and Ma L (2023) Case report: A Chinese patient with glutathione synthetase deficiency and a novel glutathione synthase mutation
This review aims to summarize the mechanisms and effects through which Scrophulariae Radix affects thyroid diseases and DM, providing further guidance for clinical treatment